Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Stuart Elborn

Showing results (161-170 of 290) with videos related to

Pageof 29
Sort By:
Plos One|October 11, 2012
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsAnthony A Fodor, Erich R Klem, Deirdre F Gilpin, et al.
The Lancet. Respiratory Medicine|June 14, 2015
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trialRichard B Moss, Patrick A Flume, J Stuart Elborn, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2015
Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patientsHussein Chalhoub, Michael Tunney, J Stuart Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 1, 2018
Cystic fibrosis epithelial cells are primed for apoptosis as a result of increased Fas (CD95)Qiwei Chen, Sudha Priya Soundara Pandi, Lauren Kerrigan, et al.
Pharmaceutics|August 7, 2019
Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary ApplicationsMarcus Hill, Matthew Twigg, Emer A Sheridan, et al.
ERJ Open Research|September 17, 2024
Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaCSivagurunathan Sutharsan, Rainald Fischer, Wolfgang Gleiber, et al.
British Journal of Biomedical Science|October 10, 2002
Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identificationJohn E Moore, Alastair Reid, Beverley C Millar, et al.
The Veterinary Record|September 30, 2008
Cystic fibrosis and the isolation of Pseudomonas aeruginosa from horsesJohn E Moore, Colin E Goldsmith, B Cherie Millar, et al.
Respiratory Medicine|July 17, 2007
Acute and latent adenovirus in COPDTerence E McManus, Anne-Marie Marley, Noreen Baxter, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2014
Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasisStephen A Rowan, Judy M Bradley, Ian Bradbury, et al.
Pageof 29

Showing results (161-170 of 290) with videos related to

Sort By:
Pageof 29
Plos One|October 11, 2012
The adult cystic fibrosis airway microbiota is stable over time and infection type, and highly resilient to antibiotic treatment of exacerbationsAnthony A Fodor, Erich R Klem, Deirdre F Gilpin, et al.
The Lancet. Respiratory Medicine|June 14, 2015
Efficacy and safety of ivacaftor in patients with cystic fibrosis who have an Arg117His-CFTR mutation: a double-blind, randomised controlled trialRichard B Moss, Patrick A Flume, J Stuart Elborn, et al.
The Journal of Antimicrobial Chemotherapy|January 15, 2015
Avibactam confers susceptibility to a large proportion of ceftazidime-resistant Pseudomonas aeruginosa isolates recovered from cystic fibrosis patientsHussein Chalhoub, Michael Tunney, J Stuart Elborn, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 1, 2018
Cystic fibrosis epithelial cells are primed for apoptosis as a result of increased Fas (CD95)Qiwei Chen, Sudha Priya Soundara Pandi, Lauren Kerrigan, et al.
Pharmaceutics|August 7, 2019
Alginate/Chitosan Particle-Based Drug Delivery Systems for Pulmonary ApplicationsMarcus Hill, Matthew Twigg, Emer A Sheridan, et al.
ERJ Open Research|September 17, 2024
Randomised, phase 1/2a trial of ION-827359, an antisense oligonucleotide inhibitor of ENaCSivagurunathan Sutharsan, Rainald Fischer, Wolfgang Gleiber, et al.
British Journal of Biomedical Science|October 10, 2002
Pandoraea apista isolated from a patient with cystic fibrosis: problems associated with laboratory identificationJohn E Moore, Alastair Reid, Beverley C Millar, et al.
The Veterinary Record|September 30, 2008
Cystic fibrosis and the isolation of Pseudomonas aeruginosa from horsesJohn E Moore, Colin E Goldsmith, B Cherie Millar, et al.
Respiratory Medicine|July 17, 2007
Acute and latent adenovirus in COPDTerence E McManus, Anne-Marie Marley, Noreen Baxter, et al.
American Journal of Respiratory and Critical Care Medicine|January 17, 2014
Lung clearance index is a repeatable and sensitive indicator of radiological changes in bronchiectasisStephen A Rowan, Judy M Bradley, Ian Bradbury, et al.
Pageof 29